NUCLEOLIN and neoplasm: In respect to the latter, our group has unraveled nucleolin as an accessible tumor-associated marker for drug delivery into solid tumors, upon intravenous administration of pegylated pH-sensitive liposomes functionalized with the nucleolin-binding F3 peptide.